Article

Xcellerex Begins Construction on New FlexFactory Biomanufacturing Facility

Xcellerex, Inc. has begun construction of a state-of-the-art current good manufacturing practices-compliant FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA.

Xcellerex, Inc. has begun construction of a state-of-the-art current good manufacturing practices-compliant FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA. Construction will be completed in September 2010.

The facility, the second FlexFactory at the Marlborough site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant also will support Xcellerex's contract manufacturing operations. The new facility will feature 2,000 L Xcellerex XDR single-use bioreactors and modular single-use downstream unit operations through bulk-product.

Xcellerex's FlexFactory is a portable manufacturing platform, based on the application of single-use technologies, controlled environmental modules, and process automation including electronic batch records.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
© 2025 MJH Life Sciences

All rights reserved.